SCHEMBL16166268

SCHEMBL16166268

COc1ccc(Cn2ncc3c2NC(=O)C[C@]32C(=O)Nc3ccc(Cl)cc32)c(OC)c1

nearest known ligand 0.42

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADAMTS5 Q9UNA0 1/20 0.37
CBX7 O95931 1/20 0.37
CDYL Q9Y232 1/20 0.37
NPBWR1 P48145 2/20 0.36
PDE9A O76083 4/20 0.36
AKR1B1 P15121 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MDM2 Q00987 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.34
P2RX3 P56373 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16175826 0.89 NPBWR1 (0.44) ADAMTS5CBX7CDYLNPBWR1AKR1B1
SCHEMBL16175837 0.87 NPBWR1 (0.44) ADAMTS5CBX7CDYLNPBWR1MEN1
SCHEMBL16166413 0.85 ADAMTS5 (0.38) ADAMTS5CBX7CDYLNPBWR1AKR1B1
SCHEMBL16166339 0.85 IP6K1 (0.42) PDE9AAKR1B1KDM4E
SCHEMBL16166482 0.85 IP6K1 (0.42) PDE9AAKR1B1KDM4E
SCHEMBL16166116 0.83 AKR1B1 (0.38) AKR1B1
SCHEMBL16166247 0.82 AKR1B1 (0.40) CBX7CDYLAKR1B1MEN1KMT2A
SCHEMBL16166401 0.82 AKR1B1 (0.40) CBX7CDYLAKR1B1MEN1KMT2A
SCHEMBL16166409 0.79 AKR1B1 (0.36) ADAMTS5CBX7CDYLNPBWR1AKR1B1
SCHEMBL16166565 0.79 HTR2C (0.38) AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014167528-A1 SPIROPYRAZOLOPYRIDINE DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF VIRAL INFECTIONS NOVARTIS AG (CH) 2014-10-16 WO disclosed
WO-2014167528-A1 SPIROPYRAZOLOPYRIDINE DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF VIRAL INFECTIONS NOVARTIS AG (CH) 2014-10-16 WO disclosed